PARAMETRIC PORTFOLIO ASSOCIATES LLC - BIOSPECIFICS TECHNOLOGIES CO ownership

BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 80 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
PARAMETRIC PORTFOLIO ASSOCIATES LLC ownership history of BIOSPECIFICS TECHNOLOGIES CO
ValueSharesWeighting
Q3 2020$1,140,000
-30.0%
21,582
-18.7%
0.00%0.0%
Q2 2020$1,628,000
+40.3%
26,561
+29.5%
0.00%0.0%
Q1 2020$1,160,000
-29.1%
20,508
-28.7%
0.00%0.0%
Q4 2019$1,637,000
+58.8%
28,749
+49.2%
0.00%0.0%
Q3 2019$1,031,000
-45.7%
19,265
-39.4%
0.00%
-50.0%
Q2 2019$1,899,000
+6.7%
31,804
+11.4%
0.00%0.0%
Q1 2019$1,779,000
+92.3%
28,546
+86.9%
0.00%
+100.0%
Q4 2018$925,000
+38.1%
15,271
+33.3%
0.00%0.0%
Q3 2018$670,000
+24.8%
11,458
-4.3%
0.00%0.0%
Q2 2018$537,000
+29.7%
11,968
+28.2%
0.00%
Q1 2018$414,0009,3350.00%
Other shareholders
BIOSPECIFICS TECHNOLOGIES CO shareholders Q2 2018
NameSharesValueWeighting ↓
JW Asset Management, LLC 73,649$3,646,0002.32%
Stonepine Capital Management, LLC 59,878$2,965,0001.60%
NORTHPOINTE CAPITAL LLC 109,644$5,428,0000.57%
Elk Creek Partners, LLC 145,406$7,199,0000.47%
TFS CAPITAL LLC 18,208$901,0000.35%
RICE HALL JAMES & ASSOCIATES, LLC 161,671$8,004,0000.35%
Ativo Capital Management LLC 19,592$970,0000.26%
Matarin Capital Management, LLC 57,034$2,823,753,0000.26%
ISTHMUS PARTNERS, LLC 16,505$817,0000.24%
Stanley-Laman Group, Ltd. 12,546$621,0000.17%
View complete list of BIOSPECIFICS TECHNOLOGIES CO shareholders